The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ben-yoram Israel since 2008.
The trader's CIK number is 1320556.
At the time of the last reporting, Ben-yoram Israel was the Director of Pluristem Therapeutics Inc. (stock ticker symbol PSTI).
Also see all insider trading activities at Pluristem Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | PSTI | 71,429 | $50,000 | 0 | $0 | 0 | $0 |
| 2015 | PSTI | 30,000 | $62,939 | 30,000 | $63,000 | 0 | $0 |
| 2014 | PSTI | 5,000 | $14,100 | 106,875 | $458,968 | 0 | $0 |
| 2013 | PSTI | 63,902 | $193,303 | 97,429 | $298,755 | 27,500 | $17,050 |
| 2009 | PSTI | 5,000 | $5,649 | 5,000 | $5,649 | 0 | $0 |
| 2008 | PSTI | 2,500 | $4,950 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-04-08 | PSTI | Buy | 71,429 | .70 | 50,000 |
| 2015-09-21 | PSTI | Buy | 30,000 | 2.10 | 62,939 |
| 2015-09-21 | PSTI | Sale | 30,000 | 2.10 | 63,000 |
| 2014-09-17 | PSTI | Buy | 5,000 | 2.82 | 14,100 |
| 2014-01-16 | PSTI | Sale | 10,725 | 4.51 | 48,337 |
| 2014-01-17 | PSTI | Sale | 24,900 | 4.51 | 112,398 |
| 2014-01-10 | PSTI | Sale | 2,080 | 4.25 | 8,840 |
| 2014-01-13 | PSTI | Sale | 24,373 | 4.30 | 104,706 |
| 2014-01-07 | PSTI | Sale | 35,625 | 4.09 | 145,706 |
| 2014-01-08 | PSTI | Sale | 9,172 | 4.25 | 38,981 |
| 2013-09-12 | PSTI | Sale | 52,000 | 3.10 | 160,940 |
| 2013-05-16 | PSTI | Buy | 63,902 | 3.02 | 193,303 |
| 2013-05-16 | PSTI | Sale | 21,500 | 3.06 | 65,790 |
| 2013-05-17 | PSTI | Sale | 18,800 | 3.01 | 56,587 |
| 2013-05-20 | PSTI | Sale | 5,129 | 3.01 | 15,438 |
| 2013-03-21 | PSTI | Option Ex | 27,500 | .62 | 17,050 |
| 2009-12-28 | PSTI | Buy | 5,000 | 1.13 | 5,649 |
| 2009-12-28 | PSTI | Sale | 5,000 | 1.13 | 5,649 |
| 2008-06-24 | PSTI | Buy | 2,500 | 1.98 | 4,950 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ben-yoram Israel (Director of Pluristem Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.